The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression

Cytokines are pleiotropic molecules with important roles in inflammatory responses. Pro-inflammatory cytokines and neuroinflammation are important not only in inflammatory responses but also in neurogenesis and neuroprotection. Sustained stress and the subsequent release of pro-inflammatory cytokines lead to chronic neuroinflammation, which contributes to depression. Hippocampal glucocorticoid receptors (GRs) and the associated hypothalamus-pituitary-adrenal (HPA) axis have close interactions with pro-inflammatory cytokines and neuroinflammation. Elevated pro-inflammatory cytokine levels and GR functional resistance are among the most widely investigated factors in the pathophysiology of depression. These two major components create a vicious cycle. In brief, chronic neuroinflammation inhibits GR function, which in turn exacerbates pro-inflammatory cytokine activity and aggravates chronic neuroinflammation. On the other hand, neuroinflammation causes an imbalance between oxidative stress and the anti-oxidant system, which is also associated with depression. Although current evidence strongly suggests that cytokines and GRs have important roles in depression, they are essential components of a whole system of inflammatory and endocrine interactions, rather than playing independent parts. Despite the evidence that a dysfunctional immune and endocrine system contributes to the pathophysiology of depression, much research remains to be undertaken to clarify the cause and effect relationship between depression and neuroinflammation.

[1]  C. Blatteis,et al.  Suppression of fever after lesions of the anteroventral third ventricle in guinea pigs , 1983, Brain Research Bulletin.

[2]  B. Aggarwal,et al.  Inflammation and cancer: how hot is the link? , 2006, Biochemical pharmacology.

[3]  D. Keating Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases , 2007, Journal of neurochemistry.

[4]  S. Lehnardt,et al.  Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injury , 2009, Glia.

[5]  Wolfgang Schreiber,et al.  Hormonal Response Pattern in the Combined DEX-CRH Test Is Stable over Time in Subjects at High Familial Risk for Affective Disorders , 1998, Neuropsychopharmacology.

[6]  B. Ravnkilde,et al.  Hippocampal volume and depression: a meta-analysis of MRI studies. , 2004, The American journal of psychiatry.

[7]  J. Cidlowski,et al.  The Physiology of Human Glucocorticoid Receptor β (hGRβ) and Glucocorticoid Resistance , 2006 .

[8]  M. Mattson,et al.  4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes , 1997, Neuroscience.

[9]  R. Sapolsky,et al.  Glucocorticoids Exacerbate Lipopolysaccharide-Induced Signaling in the Frontal Cortex and Hippocampus in a Dose-Dependent Manner , 2010, The Journal of Neuroscience.

[10]  A. Hruszkewycz Lipid peroxidation and mtDNA degeneration. A hypothesis. , 1992, Mutation research.

[11]  M. Matzuk,et al.  Glutathione synthesis is essential for mouse development but not for cell growth in culture. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Jin H. Song,et al.  Interferon γ Induces Neurite Outgrowth by Up-regulation of p35 Neuron-specific Cyclin-dependent Kinase 5 Activator via Activation of ERK1/2 Pathway* , 2005, Journal of Biological Chemistry.

[13]  W. Banks,et al.  Brain-immune communication pathways , 2007, Brain, Behavior, and Immunity.

[14]  P. Patterson,et al.  Leukemia inhibitory factor is a key regulator of astrocytic, microglial and neuronal responses in a low-dose pilocarpine injury model , 2006, Brain Research.

[15]  R. Dantzer,et al.  Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice , 2009, Molecular Psychiatry.

[16]  M. Maes,et al.  Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression , 2012, Neuroscience & Biobehavioral Reviews.

[17]  Y. Nolan,et al.  Tumour necrosis factor-α impairs neuronal differentiation but not proliferation of hippocampal neural precursor cells: Role of Hes1 , 2010, Molecular and Cellular Neuroscience.

[18]  O. Wolkowitz,et al.  Dysregulated relationship of inflammation and oxidative stress in major depression , 2013, Brain, Behavior, and Immunity.

[19]  R. Sapolsky,et al.  Novel glucocorticoid effects on acute inflammation in the CNS , 2003, Journal of neurochemistry.

[20]  Andrew H. Miller,et al.  Cytokines and Glucocorticoid Receptor Signaling , 2009, Annals of the New York Academy of Sciences.

[21]  M. Drew,et al.  Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression , 2009, Neuron.

[22]  T. Ushijima,et al.  Enhanced IL‐1β production in response to the activation of hippocampal glial cells impairs neurogenesis in aged mice , 2010, Synapse.

[23]  Deborah A Yurgelun-Todd,et al.  Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study , 2000, Biological Psychiatry.

[24]  Andiara E. Freitas,et al.  TNF-α-induced depressive-like phenotype and p38MAPK activation are abolished by ascorbic acid treatment , 2015, European Neuropsychopharmacology.

[25]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[26]  B. Leonard Inflammation, Depression and Dementia: Are they Connected? , 2007, Neurochemical Research.

[27]  Anthony J. Cleare,et al.  Different responses to dexamethasone and prednisolone in the same depressed patients , 2006, Psychopharmacology.

[28]  Jiankun Cui,et al.  Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA2-IIA expression in astrocytes and microglia , 2011, Journal of Neuroinflammation.

[29]  O. Andreassen,et al.  The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery , 2014, Psychoneuroendocrinology.

[30]  S. Szanton,et al.  Depression and Oxidative Stress: Results From a Meta-Analysis of Observational Studies , 2014, Psychosomatic medicine.

[31]  G. Chrousos,et al.  Tumor Necrosis Factor α Receptor- and Fas-associated FLASH Inhibit Transcriptional Activity of the Glucocorticoid Receptor by Binding to and Interfering with Its Interaction with p160 Type Nuclear Receptor Coactivators* , 2003, The Journal of Biological Chemistry.

[32]  G. Kreutzberg,et al.  Microglia: Intrinsic immuneffector cell of the brain , 1995, Brain Research Reviews.

[33]  M. Woodroofe Cytokine production in the central nervous system , 1995, Neurology.

[34]  A. Mouihate TLR4-mediated brain inflammation halts neurogenesis: impact of hormonal replacement therapy , 2014, Front. Cell. Neurosci..

[35]  Edward T. Bullmore,et al.  Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections , 2010, PloS one.

[36]  J. Sheridan,et al.  Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia , 2008, Journal of Neuroinflammation.

[37]  F. J. Monje,et al.  Long-term effects of maternal immune activation on depression-like behavior in the mouse , 2014, Translational Psychiatry.

[38]  J. Altman,et al.  Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats , 1965, The Journal of comparative neurology.

[39]  R. Sapolsky,et al.  Glucocorticoids Increase Excitotoxic Injury and Inflammation in the Hippocampus of Adult Male Rats , 2014, Neuroendocrinology.

[40]  Miguel Beato,et al.  Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.

[41]  N. Sousa,et al.  Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement , 2000, Neuroscience.

[42]  S. Bilbo,et al.  Early-Life Programming of Later-Life Brain and Behavior: A Critical Role for the Immune System , 2009, Front. Behav. Neurosci..

[43]  A. Hariri,et al.  A neurogenetics approach to understanding individual differences in brain, behavior, and risk for psychopathology , 2013, Molecular Psychiatry.

[44]  J. Cidlowski,et al.  Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: A mechanism for the generation of glucocorticoid resistance , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Joëls,et al.  Brain corticosteroid receptor balance in health and disease. , 1998, Endocrine reviews.

[46]  C. Pariante,et al.  Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis , 2012, Neuropsychopharmacology.

[47]  J. Ting,et al.  TNFα promotes proliferation of oligodendrocyte progenitors and remyelination , 2001, Nature Neuroscience.

[48]  B. Binder,et al.  Constant Darkness Induces IL-6-Dependent Depression-Like Behavior through the NF-κB Signaling Pathway , 2011, The Journal of Neuroscience.

[49]  R. Dantzer,et al.  Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior , 2002, Journal of Neuroimmunology.

[50]  J. Herbert,et al.  The corticoid environment: a determining factor for neural progenitors' survival in the adult hippocampus , 2004, The European journal of neuroscience.

[51]  David A Padgett,et al.  How stress influences the immune response. , 2003, Trends in immunology.

[52]  Olga V. Demler,et al.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[53]  B. Vollmayr,et al.  Neurogenesis and depression: etiology or epiphenomenon? , 2004, Biological Psychiatry.

[54]  B. Yu,et al.  Alterations in mitochondrial membrane fluidity by lipid peroxidation products. , 1994, Free radical biology & medicine.

[55]  H. Steinbusch,et al.  Kynurenine pathway in major depression: evidence of impaired neuroprotection. , 2007, Journal of affective disorders.

[56]  A. Miller,et al.  Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function , 2005, Molecular Psychiatry.

[57]  I. Adcock,et al.  p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. , 2002, The Journal of allergy and clinical immunology.

[58]  Freya Q. Schafer,et al.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. , 2001, Free radical biology & medicine.

[59]  B. Leonard Psychopathology of depression. , 2007, Drugs of today.

[60]  D. Ferriero,et al.  Selective vulnerability in the developing central nervous system. , 2004, Pediatric neurology.

[61]  J. Davis,et al.  DST studies in psychotic depression: a meta-analysis. , 1997, The American journal of psychiatry.

[62]  Andrew H. Miller,et al.  When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders , 2003 .

[63]  Toshiyuki Someya,et al.  Neonatal impact of leukemia inhibitory factor on neurobehavioral development in rats , 2004, Neuroscience Research.

[64]  Gerd Kempermann,et al.  Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells , 2005, Progress in Neurobiology.

[65]  A. Vercesi,et al.  Mitochondrial damage induced by conditions of oxidative stress. , 1999, Free radical biology & medicine.

[66]  J. Koo,et al.  IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress , 2008, Proceedings of the National Academy of Sciences.

[67]  Henrik Ahlenius,et al.  Tumor Necrosis Factor Receptor 1 Is a Negative Regulator of Progenitor Proliferation in Adult Hippocampal Neurogenesis , 2006, The Journal of Neuroscience.

[68]  K. Kisich,et al.  A Role for STAT5 in the Pathogenesis of IL-2-Induced Glucocorticoid Resistance1 , 2002, The Journal of Immunology.

[69]  H. Flor,et al.  Mice with Genetically Altered Glucocorticoid Receptor Expression Show Altered Sensitivity for Stress-Induced Depressive Reactions , 2005, The Journal of Neuroscience.

[70]  H. Hansson,et al.  Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[71]  G. Ramadori,et al.  Glucocorticoid receptor signaling in the intestinal epithelial cell lines IEC-6 and Caco-2: evidence of inhibition by interleukin-1β , 2001, International Journal of Colorectal Disease.

[72]  F. Dhabhar,et al.  The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions , 1997, Brain Research Reviews.

[73]  T. Kishimoto,et al.  Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.

[74]  L. Staib,et al.  Hippocampal volume reduction in major depression. , 2000, The American journal of psychiatry.

[75]  O. Fattal,et al.  Review of the literature on major mental disorders in adult patients with mitochondrial diseases. , 2006, Psychosomatics.

[76]  T. Ternynck,et al.  Interleukin‐1 Receptor Defect in Autoimmune NZB Mouse Brain , 1998, Annals of the New York Academy of Sciences.

[77]  I. Goshen,et al.  Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression , 2008, Molecular Psychiatry.

[78]  Anne E Carpenter,et al.  Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. , 2010, The American journal of pathology.

[79]  M. Maes,et al.  The role of the cytokine network in psychological stress , 2003, Acta Neuropsychiatrica.

[80]  M. Maes,et al.  Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. , 2002, Journal of affective disorders.

[81]  W. Banks,et al.  Bidirectional transport of interleukin-1 alpha across the blood-brain barrier , 1989, Brain Research Bulletin.

[82]  F. Pitossi,et al.  Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice , 1997, Journal of neuroscience research.

[83]  D. Umetsu,et al.  Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. , 1997, Journal of immunology.

[84]  J. P. Hamilton,et al.  Decreased hippocampal volume in healthy girls at risk of depression. , 2010, Archives of general psychiatry.

[85]  M. Zhuo,et al.  The Role of Hippocampal GluR1 and GluR2 Receptors in Manic-Like Behavior , 2008, The Journal of Neuroscience.

[86]  F. Gage,et al.  Neurogenesis in the adult human hippocampus , 1998, Nature Medicine.

[87]  S. Mukherjee,et al.  Free radical pathology and antioxidant defense in schizophrenia: a review , 1996, Schizophrenia Research.

[88]  V. Ferrans,et al.  Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction , 1995, Science.

[89]  J. Price,et al.  Neurocircuitry of Mood Disorders , 2010, Neuropsychopharmacology.

[90]  Z. Szatmáry,et al.  Inhibition of Glucocorticoid Receptor-mediated Transcriptional Activation by p38 Mitogen-activated Protein (MAP) Kinase* , 2004, Journal of Biological Chemistry.

[91]  B. Leonard,et al.  Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[92]  Andrew H. Miller,et al.  Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression , 2007, Brain, Behavior, and Immunity.

[93]  C. Pariante,et al.  Effects of Cytokines on Glucocorticoid Receptor Expression And Function , 1999 .

[94]  M. Maj,et al.  The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression , 2009, Metabolic Brain Disease.

[95]  R. Hirschfeld History and evolution of the monoamine hypothesis of depression. , 2000, The Journal of clinical psychiatry.

[96]  Gustavo Turecki,et al.  Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse , 2009, Nature Neuroscience.

[97]  C. Pariante,et al.  Antidepressant Compounds Can Be Both Pro- and Anti-Inflammatory in Human Hippocampal Cells , 2015, The international journal of neuropsychopharmacology.

[98]  M. Szyf,et al.  Differential Glucocorticoid Receptor Exon 1B, 1C, and 1H Expression and Methylation in Suicide Completers with a History of Childhood Abuse , 2012, Biological Psychiatry.

[99]  D. Miller Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule. , 2001, The Journal of pharmacology and experimental therapeutics.

[100]  R. Duman Depression: a case of neuronal life and death? , 2004, Biological Psychiatry.

[101]  C. Kirschbaum,et al.  Determinants of the NF-κB response to acute psychosocial stress in humans , 2009, Brain, Behavior, and Immunity.

[102]  Yong-Ku Kim,et al.  Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[103]  W. Pan,et al.  TNFα Transport across the Blood–Brain Barrier Is Abolished in Receptor Knockout Mice , 2002, Experimental Neurology.

[104]  J. Licinio,et al.  The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs , 2002, Molecular Psychiatry.

[105]  B. Baune,et al.  TNF-α and its receptors modulate complex behaviours and neurotrophins in transgenic mice , 2013, Psychoneuroendocrinology.

[106]  N. Decarolis,et al.  Hippocampal neurogenesis as a target for the treatment of mental illness: A critical evaluation , 2010, Neuropharmacology.

[107]  A. Miller,et al.  Interleukin 1α (IL-1α) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function , 2004, Molecular Psychiatry.

[108]  L. Qi,et al.  Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics , 2009, Psychopharmacology.

[109]  D. Barber,et al.  Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor. , 2004, Experimental cell research.

[110]  M. Werner,et al.  Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats , 2014, Behavioural Brain Research.

[111]  R. Ferrell,et al.  Brain-Derived Neurotrophic Factor Serum Levels and Genotype: Association with Depression during Interferon-α Treatment , 2013, Neuropsychopharmacology.

[112]  H. Son,et al.  Dexamethasone inhibits proliferation of adult hippocampal neurogenesis in vivo and in vitro , 2004, Brain Research.

[113]  H. Akil,et al.  Mineralocorticoid receptor function in major depression. , 2003, Archives of general psychiatry.

[114]  Angela L. Lee,et al.  Stress and depression: possible links to neuron death in the hippocampus. , 2002, Bipolar disorders.

[115]  Gerd Kempermann,et al.  Why New Neurons? Possible Functions for Adult Hippocampal Neurogenesis , 2002, The Journal of Neuroscience.

[116]  R. Krishnan,et al.  The Relation of Severity of Depressive Symptoms to Monocyte-Associated Proinflammatory Cytokines and Chemokines in Apparently Healthy Men , 2003, Psychosomatic medicine.

[117]  I. Dybedal,et al.  Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells. , 2001, Blood.

[118]  G. Kenis,et al.  Effects of antidepressants on the production of cytokines. , 2002, The international journal of neuropsychopharmacology.

[119]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[120]  K. Do,et al.  New model of glutathione deficit during development: Effect on lipid peroxidation in the rat brain , 2002, Journal of neuroscience research.

[121]  Carl Nathan,et al.  Points of control in inflammation , 2002, Nature.

[122]  Guo-Yuan Yang,et al.  Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia , 2004, Brain Research.

[123]  H. Monyer,et al.  NMDA receptor channels: Subunit-specific potentiation by reducing agents , 1994, Neuron.

[124]  A. S. Clark,et al.  Anabolic-androgenic steroid and adrenal steroid effects on hippocampal plasticity , 1995, Brain Research.

[125]  T. Jernigan,et al.  Hippocampal volume changes in healthy subjects at risk of unipolar depression. , 2010, Journal of psychiatric research.

[126]  Lili Zhou,et al.  Paroxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signaling , 2014, Journal of Neuroinflammation.

[127]  B. Ham,et al.  Association between Glucocorticoid Receptor Methylation and Hippocampal Subfields in Major Depressive Disorder , 2014, PloS one.

[128]  E. Gould,et al.  Stress inhibits the proliferation of granule cell precursors in the developing dentate gyrus , 1998, International Journal of Developmental Neuroscience.

[129]  Yong-Ku Kim,et al.  Cytokine imbalance in the pathophysiology of major depressive disorder , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[130]  E. Nestler,et al.  Nuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior , 2010, Proceedings of the National Academy of Sciences.

[131]  M. O’Banion,et al.  Adult murine hippocampal neurogenesis is inhibited by sustained IL-1β and not rescued by voluntary running , 2012, Brain, Behavior, and Immunity.

[132]  Yong-Ku Kim,et al.  Role of cytokines in atypical depression , 2012, Nordic journal of psychiatry.

[133]  Michael J Meaney,et al.  Epigenetic programming by maternal behavior , 2004, Nature Neuroscience.

[134]  P. Riederer,et al.  The glucocorticoid receptor gene exon 1-F promoter is not methylated at the NGFI-A binding site in human hippocampus , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[135]  R. Dempsey,et al.  Adult interleukin-6 knockout mice show compromisedneurogenesis , 2011, Neuroreport.

[136]  Depression in patients with rheumatoid arthritis: description, causes and mechanisms. , 2011 .

[137]  A. Nagai,et al.  Cytokines, chemokines, and cytokine receptors in human microglia , 2002, Journal of neuroscience research.

[138]  Hongjun Song,et al.  Adult neurogenesis in the mammalian central nervous system. , 2005, Annual review of neuroscience.

[139]  T. Ben-Hur,et al.  Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells , 2003, Molecular and Cellular Neuroscience.

[140]  W. Banks,et al.  Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide , 2006, Brain, Behavior, and Immunity.

[141]  R. Dantzer,et al.  Inactivation of the Cerebral NFκB Pathway Inhibits Interleukin-1β-Induced Sickness Behavior and c-Fos Expression in Various Brain Nuclei , 2005, Neuropsychopharmacology.

[142]  C. Pariante,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society The Proinflammatory Cytokine, Interleukin-1�, Reduces , 2022 .

[143]  C. Kellendonk,et al.  Genetic dissection of glucocorticoid receptor function in mice. , 1998, Current opinion in genetics & development.

[144]  Han-Yong Jung,et al.  Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[145]  R. Sapolsky,et al.  The Stressed CNS: When Glucocorticoids Aggravate Inflammation , 2009, Neuron.

[146]  M. Pfisterer,et al.  Coronary artery disease and depression. , 2004, European heart journal.

[147]  M. Fresno,et al.  The role of tumour necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system , 1998, Progress in Neurobiology.

[148]  D. Mason,et al.  Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. , 1996, Journal of immunology.

[149]  Charles L. Raison,et al.  Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.

[150]  A. Meister Glutathione metabolism and its selective modification. , 1988, The Journal of biological chemistry.

[151]  Hiroki Toda,et al.  Inflammatory Blockade Restores Adult Hippocampal Neurogenesis , 2003, Science.

[152]  J. Mendels,et al.  Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. , 1976, Archives of general psychiatry.

[153]  A. Kraft,et al.  Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment , 2008, Expert opinion on drug metabolism & toxicology.

[154]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[155]  R. S. Smith The macrophage theory of depression. , 1991, Medical hypotheses.

[156]  L. Galea,et al.  Chronic high corticosterone reduces neurogenesis in the dentate gyrus of adult male and female rats , 2010, Neuroscience.

[157]  R. Duman,et al.  A Role for MAP Kinase Signaling in Behavioral Models of Depression and Antidepressant Treatment , 2007, Biological Psychiatry.

[158]  D. Wallace A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.

[159]  F. Holsboer,et al.  The Munich vulnerability study on affective disorders: overview of the cross-sectional observations at index investigation. , 1998, Journal of psychiatric research.

[160]  Fritz A. Henn,et al.  Neurogenesis and depression: what animal models tell us about the link , 2007, European Archives of Psychiatry and Clinical Neuroscience.

[161]  William A Banks,et al.  Blood-brain barrier transport of cytokines: a mechanism for neuropathology. , 2005, Current pharmaceutical design.

[162]  S. Kanba,et al.  Suppression of Cell Proliferation by Interferon-Alpha through Interleukin-1 Production in Adult Rat Dentate Gyrus , 2006, Neuropsychopharmacology.

[163]  J. Gensel,et al.  Immune Activation Promotes Depression 1 Month After Diffuse Brain Injury: A Role for Primed Microglia , 2014, Biological Psychiatry.